|
**Overview**: Smear Examination Routine Panel**Introduction**: The Smear Examination Routine Panel is a diagnostic tool designed for routine smear analysis using prepared smear slides. In India, microscopic smear examination is essential for detecting infections (bacterial, fungal, parasitic), malignancy (cervical Pap, body fluids), and inflammatory conditions, with high utility in resource-limited settings. High morbidity from under-utilization in rural/low-SES patients with discharge, fever, or abnormal cytology, limited cytology labs, delayed diagnosis leading to progression (e.g., cervical cancer, TB). Per pathology practices aligned with ICMR and Indian Academy of Cytology guidelines, the test employs microscopy for cell morphology, WBC/RBC count, bacteria, fungi, parasites, epithelial cells, and cytology over 1-2 days with high accuracy, valuable for rapid bedside or lab assessment. This diagnostic falls under cytology screening and targets patients with infections, malignancy suspicion, or routine Pap, addressing accurate detection to guide antibiotics or biopsy. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling affordable microscopic evaluation and reducing infectious/cancer burden. Its smear-based approach ensures reliable morphological analysis.**Other Names**: Smear Routine Pnl.**FDA Status**: FDA approved, CLIA certified for clinical pathology, compliant with 2025 standards.**Historical Milestone**: Routine smear microscopy standard; in India, backbone of cytology services.**Purpose**: The test assesses 8 parameters including cell morphology to guide cytology screening, detect infection/malignancy, inform therapy.**Test Parameters**: 1. Cell Morphology, 2. WBC Count, 3. RBC Count, 4. Bacteria, 5. Fungi, 6. Parasites, 7. Epithelial Cells, 8. Cytology.**Pretest Condition**: No fasting required; patients should have relevant clinical indication.**Specimen**: 1 prepared smear slide, transported within specified times to maintain sample integrity.Sample Stability: Indefinite when properly fixed/stained; testing possible long-term.**Medical History**: Patients should provide details on symptoms, site of smear.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected pathology including progression, benefits of screening, and minimal discomfort from sample collection.**Procedural Considerations**: The test involves sample processing using microscopy by trained personnel to ensure sterile technique, avoid artifacts, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Poor smear quality, delays in fixation, or interpretation differences can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal cells/parasites/bacteria indicate infection/malignancy, necessitating specialist input.**Specialist Consultation**: Pathologists or gynecologists should be consulted for management.**Additional Supporting Tests**: Culture, biopsy for confirmation.**Test Limitations**: Subjective interpretation; comprehensive approach required.**References**: Indian Journal of Pathology and Microbiology 2024, Cytology Studies India 2023. |
